Becton Dickinson Newswire

Comprehensive Real-Time News Feed for Becton Dickinson.

Results 1 - 20 of 100 in Becton Dickinson

  1. 2017 Global Prefilled Syringes Industry Opportunities and TrendsRead the original story

    Wednesday | SBWire

    ... factors that are and will be driving the growth of the industry. Further, key players of the industry like Becton Dickinson, Unilife, Baxter, Covedian and Thermo Fisher have been profiled and growth of the industry has been predicted taking into ...

    Comment?

  2. Still Several Reasons To Remain Long AmarantusRead the original story

    Wednesday Apr 9 | Seeking Alpha

    Amarantus BioScience has spent much of the past year cleaning up its balance sheet and creating the necessary financial strength and flexibility to drive its pipeline forward.

    Comment?

  3. New Assay for Neisseria gonorrhoeae (GC) Testing Incorporates Real-Time PCR TechnologyRead the original story

    Tuesday Apr 8 | Sys-Con Media

    The BD MAX GC rt PCR assay is an in vitro diagnostic test intended for testing Neisseria gonorrhoeae positive results from the BD ProbeTeca GC Q x Amplified DNA Assay performed on the BD Vipera System with XTRa Technology.

    Comment?

  4. Supreme Court Agrees to Take Case Assessing Scope of Review for Claim ConstructionRead the original story

    Monday Apr 7 | JD Supra

    The Supreme Court on Monday, March 31, 2014, granted certiorari in Teva Pharmaceuticals USA, Inc. v.

    Comment?

  5. ISI Group Increases Becton Dickinson & Co. Price Target to $130.00Read the original story w/Photo

    Monday Apr 7 | AmericanBankingNews.com

    ... ISI Group's price objective would suggest a potential upside of 11.74% from the company's current price. Becton Dickinson & Co. ( NYSE:BDX ) opened at 116.34 on Monday. Becton Dickinson & Co. has a 52-week low of $93.06 and a 52-week high of ...

    Comment?

  6. China Pharmaceutical Glass Packaging Industry Report, 2013-2016:...Read the original story

    Saturday Apr 5 | PRWeb

    Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceutical glass packaging industry develops sluggishly.

    Comment?

  7. CR Bard Focuses on Small to Medium-Sized DealsRead the original story

    Friday Apr 4 | GuruFocus.com

    ... the company. The company has a very attractive current ratio of 33.03% which is higher than its comps: Becton Dickinson & Co ( BDX ), Cardinal Health Inc ( CAH ), Cooper Companies ( COO ) and Luxottica Group S.p.A. ( LUX ). As outlined in this ...

    Comment?

  8. Retractable Technologies, Inc. Declares Dividends to Series I and II...Read the original story

    Tuesday Apr 1 | Hispanic Business

    Dividends have accrued at 10% per annum and cover amounts in arrears from . Retractable manufactures and markets VanishPoint and Patient Safe safety medical products.

    Comment?

  9. Retractable Technologies, Inc. Declares Dividends to Series I and II...Read the original story

    Tuesday Apr 1 | Customer Interaction Solutions

    Retractable Technologies, Inc. announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,937.50 and $44,675.00, respectively.

    Comment?

  10. Benefits for the regionRead the original story

    Wednesday Mar 26 | Plymouth Evening Herald

    THE Cabinet Office has listed the Chancellor's Budget announcements most likely to affect businesses and households in the South West.

    Comment?

  11. Bear of the Day: Endologix (ELGX) - Bear of the DayRead the original story

    Tuesday Mar 25 | Investopedia

    About the Company Headquartered in Irvine, California, Endologix develops, manufactures, markets and sells minimally invasive treatments for vascular diseases.

    Comment?

  12. Becton Dickinson & Co. Given Neutral Rating at ZacksRead the original story w/Photo

    Wednesday Mar 26 | AmericanBankingNews.com

    ... higher raw material costs and other macroeconomic headwinds. The stock has a target price of $120.00." Becton Dickinson & Co. ( NYSE:BDX ) traded up 0.88% on Wednesday, hitting $115.32. 413,600 shares of the company's stock traded hands. Becton ...

    Comment?

  13. Global Gynecological Cancers Market 2014-2018Read the original story

    Wednesday Mar 26 | Sys-Con Media

    TechNavio's analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018.

    Comment?

  14. Global blood collection systems market: 10.1% CAGR growth forecast between 2012-16Read the original story w/Photo

    Tuesday Mar 25 | PR-inside.com

    ... on high cost automated blood collection systems. The key vendors dominating this market space are Becton Dickinson & Co., Fresenius Kabi AG, Haemonetics Corp., and Terumo Penpol Ltd. Other vendors are Grifols SA, Hemagen Diagnostics Inc., Immucor ...

    Comment?

  15. Becton, Dickinson and Company - Mergers & Acquisitions (M&A),...Read the original story

    Friday Mar 21 | SBWire

    MarketLine's Company Mergers & Acquisitions , Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

    Comment?

  16. Unilife Finally Secures Its Financial SituationRead the original story

    Mar 13, 2014 | Seeking Alpha

    ... their IP protection and business model solid. Competition from the largest player in the syringe space, Becton Dickinson ( BDX ), does not seem to be a real issue for Unilife either - although short sellers certainly wish it was at this point. I ...

    Comment?

  17. Therasense Inc v. Becton Dickinson and Company LLCRead the original story

    Mar 12, 2014 | FindLaw

    THERASENSE, INC. and Abbott Laboratories, Plaintiffs -Appellees, v. BECTON, DICKINSON AND COMPANY and Nova Biomedical Corporation, Defendants-Appellants, Bayer Healthcare LLC, Defendant.

    Comment?

  18. Harvard Bioscience Names Names Vice President Global Operations and QualityRead the original story

    Mar 10, 2014 | Pharmaceutical Processing

    Harvard Bioscience, a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, has named Ronald Aplin to Vice President Global Operations and Quality, effective immediately.

    Comment?

  19. MRI Interventions Welcomes Medical Device Operational Specialist...Read the original story

    Mar 10, 2014 | GlobeNewswire

    ... Medical, Mr. Richards held a number of progressive leadership positions throughout the U.S. and Asia with Becton Dickinson and Company. Mr. Richards received his B.A. from Lake Forest College, and he has participated in executive management and ...

    Comment?

  20. Harvard Bioscience Names Ronald Aplin to Vice President Global Operations and QualityRead the original story

    Mar 10, 2014 | GlobeNewswire

    Harvard Bioscience, Inc. , a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, has named Ronald Aplin to Vice President Global Operations and Quality, effective immediately.

    Comment?